The Impact of Hypomethylating Agents and BCL-2 Inhibitor on HLA Expression on THP-1 Cells
Benjamin Peton(City Of Hope National Medical Center), Ketevan Gendzekhadze(City Of Hope National Medical Center), Monzr M. Al Malki(City of Hope), Lucy Ghoda(City Of Hope National Medical Center), Guido Marcucci(City of Hope), Melissa Valerio(City Of Hope National Medical Center), Ivan Rodriguez(City of Hope), Michiko Taniguchi(City of Hope), Ebtsesam Nafie(City of Hope)
Cited by 2
Related Papers
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a <i>FLT3</i> Mutation
|New England Journal of Medicine|2017|2.2k
<i>IDH1</i> and <i>IDH2</i> Gene Mutations Identify Novel Molecular Subsets Within De Novo Cytogenetically Normal Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study
|Journal of Clinical Oncology|2010|764
Acute Myeloid Leukemia, Version 3.2017, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2017|655